Research Article

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS

Table 1

Chemical identification of BYF by UHPLC-Q-extractive Orbitrap MS/MS.

No.RTFormulaIdentificationm/z [M + H]+Error (ppm)MS/MSOrigin

11.43C7H6O34-Hydroxybenzoic acid isomer139.03862.68121.0281[M + H-H2O]+; 95.04889[M + H-CO2]+PF
21.45C7H12O6Quinic acidR193.07022.42147.0650[M + H-CH2O-O]+; 129.0544[M + H-CH2O-O-H2O]+; 111.0439[M + H-CH2O-O-2H2O]+EH
31.49C36H36N2O8Lyciumamide B625.25410.55607.2366[M + H-H2O]+; 589.2355CFM_IDLF
41.51C7H6O5Gallic acid isomer171.02832.94153.0199[M + H-H2O]+; 127.0386[M + H-CO2]+MBPRR/AJH
51.55C7H6O34-Hydroxybenzoic acid139.03862.68121.0281[M + H-H2O]+; 95.0490[M + H-CO2]+PF
61.75C13H18O7Isosalicin287.11124.65125.0594[M + H-glu]+PRR
71.95C6H6O25-Methyl furan aldehyde111.04382.3383.0489[M + H-CO]+SCF
81.95C9H11NO2Phenylalanine isomer166.08601.5591.0539MoNAPF
91.97C9H8O3p-Hydroxy-cinnamic acid165.05431.95121.0635[M + H-CO2]+ MoNALF, PF
102.22C5H7NO3Pyroglutamic acidR130.0499−0.2484.0442PF
1111.23C14H16O9Bergenin329.0880−3.94311.0752[M + H-H2O]+; 293.0647[M + H-2H2O]+; 275.0543[M + H-3H2O]+; 263.0543; 233.0439AJH
1211.69C16H18O9Cis-Cryptochlorogenic acid/trans-Cryptochlorogenic acid/Chlorogenic acid355.1045−6.05163.0376MBEH
1311.82C39H50O26Quercetin-rha-tri-hex935.2681−1.92303.0463[M + H-rha-3hex]+LF
1411.96C23H28O12OxypaeoniflorinR497.1668−2.92335.1158[M + H-glu]+; 133.0636; 121.0282PR
1512.00C17H26O10LoganinR391.1616−4.43229.1065[M + H-glu]+; 197.0808; 179.0699PF, AJH/AJH
1616.15C27H30O14Apigenin-rha-glu579.1729−3.58433.1132[M + H-rha]+; 271.0596[M + H-rha-glu]+FTB, EH
1716.21C32H38O16Hexandraside E679.2266−4.92517.1617[M + H-glu]+; 355.1173[M + H-2glu]+; 299.0549[M + H-2glu-isobutenyl]+EH
1816.23C21H20O11Kaempferol-3-O-gal449.1095−3.71287.0539[M + H-glu]+; 263.0550; 245.0442AJH, EH/FTB, EH
1916.35C23H28O11Albiflorin481.1723−3.88319.1169[M + H-glu]+PR
2016.55C27H30O14RhoifolinR579.1729−3.58433.1132[M + H-rha]+; 271.0596[M + H-rha-glu]+EH
2116.72C22H22O10Calycosin-7-O-glu or its isomer (a)447.1287−0.28285.0749[M + H-glu]+AR
2216.79C28H34O15HesperidinR611.1998−4.51465.1387[M + H-rha]+; 303.0860[M + H-rha-glu]+; 177.0545; 153.0181; 85.0283CRP
2316.81C18H16O7Dihydroxy-trimethoxyflavone345.0985−4.71287.0555[M + H-2CH3-CO]+; 153.0179CRP
2416.81C22H24O11Hesperetin-7-O-glu or its isomer (a)465.1396−1.00303.086[M + H-glu]+GRR
2516.89C21H22O10Prunin435.1294−1.90417.0648[M + H-H2O]+; 343.1283; 273.0755[M + H-glu]+CRP
2616.93C18H16O8Rosmarinic acidR361.09073.04163.0384; 145.0273; 135.0429PF/CRP
2716.97C33H53NO8Sibelicin glycoside592.38430.16574.3731[M + H-H2O]+; 430.3316[M + H-glu]+; 412.3208[M + H-glu-H2O]+FTB
2817.09C22H22O11Diosmetin-6-C-glu/Pratensein-7-O-glu (a)463.1247−2.62301.0703[M + H-glu]+CRP/AR
2917.15C21H20O10Apigenin-8-C-glu433.1146−3.88271.0602[M + H-glu]+CRP
3017.19C28H32O15DiosminR609.1825−1.81463.1224[M + H-rha]+;301.0696[M + H-rha-glu]+;286.0461[M + H-rha-glu-CH3]+CRP
3117.31C27H41NO3Peimisine isomer (a)428.3171−2.76410.3067[M + H-H2O]+FTB
3217.43C17H14O8Tetrahydroxy-dimethoxyflavone (a)347.07532.44287.0543[M + H-2OCH3]+CRP
3317.47C21H18O11Apigenin-7-O-gluA447.0931−2.04271.0589[M + H-gluA]+; 167.0556PF
3417.72C27H41NO3PeimisineR428.3171−2.76410.3026[M + H-H2O]+FTB
3517.86C32H38O15Des-O-methylicariin/epimedoside A663.2299−2.35517.1711[M + H-rha]+; 355.1168[M + H-rha-glu]+; 299.0544[M + H-rha-glu-isobutenyl]+EH
3617.94C22H22O11Diosmetin-6-C-glu/pratensein-7-O-glu (b)463.12421.54301.0701[M + H-glu]+CRP/AR
3718.00C15H16O4Meranzin/isomeramazin (a)261.11171.67189.0547; 131.0487MBCRP
3818.30C16H14O6Hesperetin303.0875−3.92177.0547; 171.0288; 153.0182 [24]CRP
3918.30C22H24O11Hesperetin-7-O-glu or its isomer (b)465.1396−1.00303.0856[M + H-glu]+GRR
4018.52C27H41NO3Peimisine isomer (b)428.3171−2.76410.3055[M + H-H2O]+FTB
4119.03C33H55O8NZhebeininoside594.4004−0.60576.3881[M + H-H2O]+; 414.3357[M + H-H2O-glu]+FTB
4219.17C27H45NO3Peimine AR432.3473−0.81414.3361[M + H-H2O]+; 398.3082FTB
4319.91C27H41NO3Peimisine isomer (c)428.3171−2.76410.2988[M + H-H2O]+; 337.2122FTB
4420.15C27H41O4NPeimisine nitrogen oxide444.31021.43398.3026[M + H-CH2O-O]+; 98.0961FTB
4520.23C27H41NO3Peimisine isomer (d)428.3171−2.76410.2950[M + H-H2O]+FTB
4621.17C9H10O3Ethyl 4-hydroxybenzoate167.07001.63123.0436[M + H-C2H2O]+EH
4721.2C23H26O10Lactiflorin463.15882.32167.0701; 123.0441 [25]PR
4821.26C15H12O5Naringenin isomer (a)273.07502.76247.0427 [24]CRP
4921.32C27H43NO3Peiminine BR430.33062.26412.3206[M + H-H2O]+; 396.2866FTB
5021.53C39H50O20Epimedin A (hexandraside F) isomer839.29531.81677.2344[M + H-glu]+; 531.1817[M + H-glu-rha]+; 369.1326[M + H-2glu-rha]+; 313.0698[M + H-2glu-rha-isobutenyl]+EH
5121.78C33H53NO7Yibeinoside A or its isomer (a)576.38802.57414.3339[M + H-glu]+FTB
5221.80C9H10O3Paeonol isomer167.07001.63149.0582[M + H-H2O]+; 121.0644[M + H-H2O-CO]+PRR
5322.20C18H19NO4N-E-feruloyl tyramine314.13773.14177.0543; 145.0283; 121.0646LF
5422.26C27H30O11Neoicariin/wushanicariin/icariside I or their isomer (a)531.18521.68369.1323[M + H-glu]+; 313.0701[M + H-glu-isobutenyl]+EH
5522.38C39H50O20Epimedin A (hexandraside F)R839.29442.89677.2318[M + H-glu]+; 531.1852[M + H-glu-rha]+; 369.1326[M + H-2glu-rha]+; 313.0697[M + H-2glu-rha-isobutenyl]+EH
5622.42C28H34O14Poncirin/didymin595.20023.25433.1456[M + H-glu]+; 287.0909[M + H-glu-rha]+; 171.0285; 153.0180CRP
5722.45C22H22O9Ononin415.13760.11283.0845[M + H-glu]+; 219.0253; 183.0275; 132.0433; 89.0590AR
5822.51C16H12O5CalycosinR285.07483.34171.0275; 161.0595AR
5922.51C28H32O14Robinia pseudoxanthin-7-O-rutinoside593.18502.50447.1188[M + H-rha]+; 285.075[M + H-rha-glu]+PF
6022.98C38H48O19Epimedin BR809.28412.67677.2428[M + H-xyl]+; 531.1852[M + H-xyl-rha]+; 369.1324[M + H-xyl-rha-glu]+; 313.0698[M + H-xyl-rha-glu-isobutenyl]+EH
6122.98C27H30O11Neoicariin/wushanicariin/icariside I or their isomer (b)531.18521.68369.1326[M + H-glu]+; 313.0699[M + H-glu-isobutenyl]+EH
6223.13C33H53NO7Yibeinoside A or its isomer (b)576.38782.92414.3355[M + H-glu]+FTB
6323.26C27H30O11Neoicariin/wushanicariin/icariside I or their isomer (c)531.18521.68369.1328[M + H-glu]+; 313.0699[M + H-glu-isobutenyl]+EH
6423.28C39H50O19Epimedin C (baohuside VI)R823.29992.44677.2422[M + H-rha]+; 531.1848[M + H-2rha]+; 369.1324[M + H-2rha-glu]+; 313.0698[M + H-3rha-glu]+EH
6523.34C27H41NO3Peimisine isomer (e)428.3171−2.76410.3058[M + H-H2O]+FTB
6623.40C30H34O17Sudachiin B/C667.18601.32361.0916; 346.0653; 315.0478 [24]CRP
6723.52C27H45NO3Isopeimine A432.34730.05414.3356[M + H-H2O]+FTB
6823.58C21H20O6Anhydroicaritin or its isomer (a)369.13281.26323.0738; 313.0687[M + H-isobutenyl]+EH
6923.60C33H40O15IcariinR677.24232.51531.1846[M + H-rha]+; 369.1322[M + H-rha-glu]+; 311.0697[M + H-rha-glu-isobutenyl]+EH
7023.60C27H30O11Neoicariin/wushanicariin/icariside I or their isomer (d)531.18521.68369.1323[M + H-glu]+; 313.0698[M + H-glu-isobutenyl]+EH
7123.68C47H78O19Astragaloside V/VI/VII947.51902.12437.3372; 419.3230 [26]AR
7223.69C36H62O920(R)-Ginsenoside Rh1639.44581.35405.3482; 423.3584; 441.368 [27]GRR
7323.72C22H22O10Calycosin-7-O-glu or its isomer (b)447.1287−0.28285.0751[M + H-glu]+; 149.0223; 89.0594AR
7423.77C33H55NO7Hupeheninoside578.40392.13416.3525[M + H-glu]+FTB
7523.85C15H12O5Naringenin isomer (b)273.07502.76247.0638; 171.0307; 153.0204 [2]CRP
7623.87C41H52O21Epimedin I881.3035−4.38531.1829[M + H-glu-acetyl rha]+; 369.1328[M + H-glu-acetyl rha-glu]+; 313.0697[M + H-glu-acetyl rha-glu-isobutenyl]+EH
7723.91C27H32O11Icaritin-3-O-rha533.20071.95387.1393[M + H-rha]+; 369.1314[M + H-rha-H2O]+; 313.0701[M + H-rha-H2O-isobutenyl]+EH
7823.99C27H43NO3Peiminine B isomer430.33062.26412.3210[M + H-H2O]+FTB
7924.05C48H82O18Ginsenoside ReR947.55314.53325.1117GRR
8024.07C54H92O23Ginsenoside Rb1R1109.60970.47487.1687; 425.3734; 325.1105GRR
8124.09C40H50O20Sempervirenoside B851.29452.73369.1315[M + H-glu-rha (OAc)-xyl]+; 313.0700[M + H-glu-rha (OAc)-xyl-isobutenyl]+EH
8224.21C33H40O18Melitidin725.22692.54419.1328; 389.0858; 361.0910 [24]CRP
8324.23C26H28O11Epimedoside C517.16902.79355.1173[M + H-glu]+; 299.0547[M + H-glu-isobutenyl]+EH
8424.2C53H90O22Ginsenoside Rb2/ginsenoside Rc/ginsenoside Rb31079.6003−0.6457.1532; 425.3733; 407.3638; 325.1110 [27]GRR
8524.31C53H90O22Ginsenoside Rb2/ginsenoside Rc/ginsenoside Rb31079.59662.83457.1523; 425.3726; 325.1110GRR
8624.35C10H14OPerillaldehydeR151.11142.28123.0438; 95.0489PF
8724.37C20H18O6Desmethylanhydroicaritin or its isomer (a)355.1197−5.89299.0546[M + H-isobutenyl]+EH
8824.37C9H10O3Paeonol167.06982.83149.0579; 121.0641GRR
8924.39C36H56O9Calenduloside E633.39812.55439.3530 [27]GRR
9024.39C48H76O19Ginsenoside Ro957.5087−3.50439.3530; 414.3343 [27]GRR
9124.41C27H43NO2Ebeiedinone/delavinone/zhebeirine (puqiedinone) (a)414.33543.04396.3243[M + H-H2O]+FTB
9224.43C41H68O14Astragaloside IvR785.46691.64587.3879; 455.3473; 437.3373; 419.3258AR
9324.47C43H54O22Epimedokoreanoside I923.31631.79719.2438[M + H-glu (OAc)]+; 531.1782[M + H-glu (OAc)-rha (OAc)]+; 369.1328[M + H-glu (OAc)-rha (OAc)-glu]+; 313.0699[M + H-glu (OAc)-rha (OAc)-glu-isobutenyl]+EH
9424.5C30H32O12Benzoylpaeoniflorin/paeonivayin or their isomer (a)585.19640.43123.0432 [25]PR
9524.51C15H12O5NaringeninR273.07502.76247.0639; 229.0517; 171.0307; 153.0183; 147.0442CRP
9624.51C15H24OSpathulenol221.18961.78203.1772[M + H-H2O]+EH
9724.59C15H10O5ApigeninR271.05932.96245.0643[M + H-O]+; 229.0854; 177.0542; 121.0281; 107.0488PF
9824.61C35H42O16Epimedokoreanoside II/sagittatoside C719.25213.43369.1332[M + H-glu-rha (OAc)]+; 313.0700[M + H-glu-rha (OAc)-isobutenyl]+EH
9924.63C31H36O14Ikarisoside F633.21612.66355.1166[M + H-rha-xyl]+; 299.0546[M + H-rha-xyl-isobutenyl]+EH
10024.69C27H43NO2Ebeiedinone/delavinone/zhebeirine (puqiedinone) (b)414.33543.04396.3246[M + H-H2O]+FTB
10124.69C33H53NO7Yibeinoside A or its isomer (c)576.38723.96558.3722[M + H-H2O]+; 396.3239[M + H-H2O-glu]+FTB
10224.73C15H24OCaryophyllene oxide or its isomer (a)221.18961.78203.1786[M + H-H2O]+CFM-IDPF/AJH
10324.81C36H62O920(S)-ginsenoside Rh1639.44782.66441.3716; 423.3512; 405.3509GRR
10424.81C16H12O6Chrysoeriol301.06982.88286.0468[M + H-CH3]+; 258.0519[M + H-CH3-CO2]+; 177.0544; 153.0182 [28]PF, AR
10524.83C15 H22 OChamigrenal isomer or its isomer (a)219.17372.94203.1425; 121.1009CFM-IDSCF
10624.93C45H56O23Caohuoside A (epimedin L)/caohuoside B/epimedin K (korepimedoside B)965.32652.09369.1313[M + H-glu (2OAc)-rha (OAc)-glu]+; 313.0694[M + H-glu (2OAc)-rha (OAc)-glu-isobutenyl]+EH
10724.93C18H16O8Trihydroxy-trimethoxyflavone361.09073.04331.0441[M + H-2CH3]+CRP
10824.97C43H70O15Astragaloside II/isoastragaloside II827.47613.20629.3947; 175.0599[Xyl (OAc)+H]+ 157.0494[Xyl (OAc)+H-H2O]+ [26]AR
10924.99C18H16O9Tetrahydroxy-trimethoxyflavone377.08572.68362.0611[M + H-CH3]+; 347.0385[M + H-2CH3]+; 319.0427[M + H-2CH3-CO]+CRP
11025.01C26H28O10Baohuoside II501.17383.45355.1169[M + H-rha]+; 299.0544[M + H-rha-isobutenyl]+; 121.0274EH
11125.01C20H18O6Desmethylanhydroicaritin or its isomer (b)355.1197−5.89299.0546[M + H-isobutenyl]+EH
11225.13C17H14O8Tetrahydroxy-dimethoxyflavone (b)347.07532.44287.0533[M + H-2OCH3]+CRP
11325.15C21H20O6Anhydroicaritin or its isomer (b)369.13281.26313.0700[M + H-isobutenyl]+EH
11425.15C33H40O15Anhydroicaritin-3-O-Γ-L-rhamnosyl-7-O-Δ-D-Glucopyranoside/sagittatoside A677.24262.07369.1324[M + H-glu-rha]+; 313.0700[M + H-glu-rha-isobutenyl]+; 225.1012EH
11525.21C30H32O12Benzoylpaeoniflorin/paeonivayin or their isomer (b)585.19512.66123.0437 [25]PR
11625.23C48H78O18Soyasaponin I943.52431.90441.3683; 423.3577CFM-IDAR
11725.34C16H12O4FormononetinR269.08060.88254.0566; 237.0544; 213.0908;AR
11825.34C19H20O7Monohydroxy-tetramethoxyflavanone361.12732.44211.0574 [24]CRP
11925.34C20H22O7Pentamethoxyflavanone (a)375.14341.15211.0588 [24]CRP
12025.38C21H20O6Anhydroicaritin or its isomer (c)369.13281.26313.7[M + H-rha-isobutenyl]+EH
12125.38C32H38O14Sagittatoside B647.23221.91515.1830[M + H-xyl]+; 369.1330[M + H-xyl-rha]+; 313.0702[M + H-xyl-rha-isobutenyl]+EH
12225.42C33H40O142″-O-rhamnosylicariside II/anhydroicaritin 3-O-2″-rha-rha661.24762.25515.1898[M + H-rha]+; 369.1328[M + H-2rha]+; 313.0699[M + H-2rha-isobutenyl]+EH
12325.54C27H41NO3Peimisine isomer (f)428.3171−2.76410.3037[M + H-H2O]+FTB
12425.56C15H16O4Meranzin/isomeramazin (b)261.11171.67189.0536; 131.0483MBCRP
12525.59C42H72O13Ginsenoside Rg2R785.50232.89441.3702; 423.3601 [27]GRR
12625.66C20H20O7IsosinensetinR373.12751.83357.0966; 343.0877; 315.0858CRP
12725.72C27H30O11Neoicariin/wushanicariin/icariside I or their isomer (e)531.18521.68369.1325[M + H-glu]+; 313.0700[M + H-isobutenyl]+EH
12825.78C45H72O16Astragaloside I/isoastragaloside I869.4894−0.10157.0482[Xyl (OAc) + H-H2O]+ [26]AR
12925.86C21H22O8Hexamethoxyflavone (a)403.13811.6388.1140; 373.0914; 358.0642; 327.0588 [24]CRP
13025.92C26H32O8Deacetylnomilin473.21631.47161.0598 [24]CRP
13125.94C36H60O8Ginsenoside Rk3/Rh4621.43472.25405.3362 [28]GRR
13226.02C21H20O6Anhydroicaritin or its isomer (d)369.13281.26313.0699[M + H-isobutenyl]+EH
13326.02C27H30O10Icariside II (baohuside I)515.19070.92369.1328[M + H-rha]+; 313.0701[M + H-rha-isobutenyl]+EH
13426.16C20H20O7Sinensetin373.12790.75357.0968; 343.0805; 329.1013; 297.0734 [24]CRP
13526.24C11H16OJasmonane165.12730.56123.1172MoNAPF
13626.26C22H26O6Gomisin L1 or its isomer (a)387.18000.56287.0549[M + H-C5H10-2CH3]+SCF
13726.26C11H14O2Methyl eugenolR179.1067−0.25151.0752; 116.9718PF
13826.28C19H18O6Tetramethyl-O-scutellarein/tetramethyl-O-isoscutellarein/tetramethoxyflavone (a)343.11730.92313.0701[M + H-2CH3]+; 285.0751[M + H-2CH3-CO]+CRP
13926.34C20H22O7Pentamethoxyflavanone (b)375.14360.61211.0596; 150.0304 [24]CRP
14026.42C18H39NO3D-ribo-phytosphingosineR318.29981.48300.2895[M + H-H2O]+; 282.2784[M + H-2H2O]+;PF
14126.48C24H32O7Schisandrol AR433.2128−0.05415.2106[M + H-H2O]+; 400.1871[M + H-H2O-CH3]+; 384.1922; 369.1688; 338.1504SCF
14226.57C19H18O8Rosmarinic acid methylester375.1076-0.42135.0435PF
14326.61C21H22O8NobiletinR403.13840.86388.1145[M + H-CH3]+; 373.0912[M + H-2CH3]+; 358.0672[M + H-3CH3]+; 327.0857; 301.0701CRP
14426.63C18H32O313-Hydroxy-9,11-octadecadienoic acid or its isomer (a)297.24162.77279.2318[M + H-H2O]+; 261.2202[M + H-2H2O]+AR
14526.63C18H30O2a-Linolenic acid or its isomer (a)279.23083.80261.2190[M + H-H2O]+; 149.0232; 121.0282MoNAPF/EH
14626.83C19H18O6Tetramethyl-O-scutellarein/tetramethyl-O-isoscutellarein/tetramethoxyflavone (b)343.11740.63313.0701[M + H-2CH3]+; 285.0750[M + H-2CH3-CO]+CRP
14726.97C22H24O93,5,6,7,8,3′,4′-heptamethoxyflavone433.14881.18418.1244[M + H-CH3]+; 403.1016[M + H-2CH3]+; 388.0700[M + H-3CH3]+; 373.0541[M + H-4CH3]+ [24]CRP
14827.07C18H32O313-hydroxy-9,11-octadecadienoic acid or its isomer (b)297.24162.77279.2313[M + H-H2O]+; 261.2217[M + H-2H2O]+AR
14927.17C42H70O12Ginsenoside Rg5/Rk1767.49321.05605.4375[M + H-glu]+; 439.3837; 425.3744; 407.3635GRR
15027.29C23H28O7Schisandrol B/epigomisin O417.19001.87399.1796[M + H-H2O]+; 368.1609; 299.0598; 119.0854SCF
15127.29C20H20O7TangeretinR373.12771.29343.0807[M + H-2CH3]+; 297.0753; 229.0328; 135.0437CRP
15227.39C28H34O9Schisantherin C (angeloylgomisin P) or its isomer (a)515.22583.42385.1667 [M + H-C4H6COOH-CH2O]+; 355.1537[M + H-C4H6COOH-2CH2O]+; 339.1198; 316.0930; 301.0690SCF
15327.75C21H22O8Hexamethoxyflavone (b)403.13801.85388.1145[M + H-CH3]+; 373.0913[M + H-2CH3]+; 355.0803[M + H-CH3-H2O]+; 327.0856[M + H-CH3-CO]+ [24]CRP
15427.89C28H36O8Angeloylgomisin H or its isomer (a)501.24731.99483.2372[M + H-H2O]+; 437.1929; 401.1953[M + H-C4H6COOH]+SCF
15527.93C23H28O6Schisandrin B (γ-schisandrin) isomer (a)401.19453.41386.1718[M + H-CH3]+; 370.1762; 355.1531; 345.1320SCF
15627.95C20H22O7Pentamethoxyflavanone (c)375.14321.68357.0634; 211.0595 [24]CRP
15728.01C28H34O8Benzoyl isogomisin O or its isomer499.2328−0.31483.2370[M + H-O]+; 451.2118[M + H-O-CH3OH]+SCF
15828.09C15 H22 OChamigrenal isomer or its isomer (b)219.17372.94203.1429CFM-IDSCF
15928.12C23H28O6Schisandrin B (γ-schisandrin) isomer (b)401.19453.41386.1718[M + H-CH3]+; 370.1764; 355.1530; 345.1324SCF
16028.14C28H36O8Angeloylgomisin H or its isomer (b)501.24692.79483.2372[M + H-H2O]+; 437.1929; 401.1955[M + H-C4H6COOH]+; 370.1768SCF
16128.26C22H26O6Gomisin L1 or its isomer (b)387.18000.56287.0548[M + H-C5H10-2CH3]+SCF
16228.36C18H30O2a-Linolenic acid or its isomer (b)279.23083.80263.2362; 149.0232; 121.0282; 95.0854MoNAPF/EH
16328.46C21H22O9Natsudaidai419.13262.53389.0862[M + H-2CH3]+; 361.0892[M + H2CH3CO]+; 299.0611; 181.0855CRP
16428.46C22H24O6Schisandrin C isomer385.16313.81355.1545[M + H-CH2O]+; 337.1415[M + H-CH2O-H2O]+; 316.0928SCF
16528.52C30H34O8Benzoyl gomisin H523.23142.38505.2202[M + H-H2O]+; 401.1912; 370.1731SCF
16628.52C25H26O6Epimedokoreanin B423.17902.88311.0522[M + H-2isobutenyl]+EH
16728.52C23H30O6Gomisin K1403.21052.52388.1869[M + H-CH3]+; 371.1848; 340.1656; 333.1236; 302.1237SCF
16828.56C30H48O4Corosolic acidR473.36142.41409.3441; 205.1585; 189.1642; 177.1634; 95.0853PF
16928.95C28H34O9Schisantherin BR515.22661.87415.1732[M + H-C4H6COOH]+SCF
17029.00C22H26O6Gomisin L1 or its isomer (c)387.18000.56355.1521[M + H-CH3OH]+; 317.1023[M + H-C5H10]+; 287.0540[M + H-C5H10-2CH3]+SCF
17129.00C23H26O7Neoisostegane415.17402.73397.1630[M + H-H2O]+; 371.1483[M + H-CO2]+; 356.1243; 340.1299SCF
17229.00C23H30O6Schisanhenol403.21052.52388.1877[M + H-CH3]+; 371.1856[M + H-CH3-OH]+; 356.1614; 340.1665; 325.1429; 305.1322SCF
17329.04C30H32O9Schisantherin AR537.21091.88415.1724; 268.9779; 91.0565SCF
17429.06C15 H22 OChamigrenal isomer or its isomer (c)219.17372.94203.1438CFM-IDSCF
17529.14C28H34O9Schisantherin C (angeloylgomisin P) or its isomer (b)515.22583.42385.1630 [M + H-C4H6COOH-CH2O]+; 355.1498[M + H-C4-H6COOH-2CH2O]+; 339.1175; 316.0931; 301.0695SCF
17629.30C22H26O6Gomisin L1 or its isomer (d)387.18000.56355.0541[M + H-CH3OH]+; 317.1023[M + H-C5H10]+; 287.0536[M + H-C5H10-2CH3]+SCF
17729.50C22H22O7Baohuosu399.14253.34355.1163[M + H-C3H6]+; 325.1052EH
17829.59C18H32O313-Hydroxy-9,11-octadecadienoic acid or its isomer (c)297.24162.77279.2316[M + H-H2O]+; 261.2198[M + H-H2O]+AR
17929.63C28H34O9Schisantherin C (angeloylgomisin P) or its isomer (c)515.22583.42385.1630[M + H-C4H6COOH-CH2O]+; 355.1525[M + H-C4H6COOH-2CH2O]+; 339.1222; 316.0939; 301.0708SCF
18029.71C22H26O6Gomisin L1 or its isomer (e)387.18000.56355.1543[M + H-CH3OH]+; 317.1017[M + H-C5H10]+; 287.0540[M + H-C5H10-2CH3]+SCF
18129.71C19H20O6Tetramethoxyflavanone345.13213.38330.1086[M + H-CH3]+; 315.0858[M + H-2CH3]+; 297.0932[M + H-2CH3-H2O]+; 287.0883[M + H-2CH3-CO]+; 247.0438CRP
18229.96C15 H22 OChamigrenal isomer or its isomer (d)219.17372.94203.1438; 149.0594; 135.0803; 121.1005CFM-IDSCF
18330.27C24H32O6Schisandrin AR417.22583.28402.2029[M + H-CH3]+; 386.2079[M + H-CH3-O]+; 371.1832[M + H-2CH3-O]+; 347.1481; 316.1296; 301.1062SCF
18430.92C18H30O2a-linolenic acid or its isomer (c)279.23083.80263.2366; 149.0231; 121.0282; 95.0853MoNAPF/EH
18531.1C23H28O6Schisandrin BR401.19453.41386.1717; 370.1769; 355.1532; 331.1166; 300.0985; 285.0753; 270.0878SCF
18631.16C15H24Trans-α-acacia205.19433.81107.0849; 93.0694; 69.0696MoNAPF
18731.18C15H24OCaryophyllene oxide or its isomer (b)221.18942.69203.1775[M + H-H2O]+CFM-IDPF/AJH
18831.22C12H16O7ArbutinR273.09583.97157.0121; 139.0016; 129.0180SCF
18931.75C22H24O6Schisandrin CR385.16313.81355.1518; 315.0834; 285.0753; 257.0812; 228.0695SCF

R: standard references; MB: massban. MoNA: massbank of North America; CFM-ID: CFM-ID.